Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Body iron stores encompass the total iron available in the body, primarily stored intracellularly as the protein **ferritin** and, in overload states, as **hemosiderin**[4]. Ferritin is a globular, 24-subunit protein with a hollow cavity capable of storing up to 4,500 iron atoms as Fe(III), serving as the main regulated intracellular iron buffer[3][6]. Hemosiderin is a less structured, insoluble aggregate formed from ferritin breakdown once storage capacity is exceeded, commonly found in liver, spleen, bone marrow, and muscle[4]. Regulation of iron storage involves iron-responsive elements (IREs) in mRNA and iron regulatory proteins (IRPs), which control translation of proteins such as ferritin and transferrin receptors, adapting to body iron supply[1]. Iron stores are essential for growth, DNA synthesis, immunity, and erythropoiesis, but excessive accumulation leads to cellular toxicity, oxidative stress, and organ failure[2][4][6]. In summary: "Body iron stores" is not a molecule or receptor and should not be used as a canonical drug target. The relevant molecular targets are the proteins involved in iron storage and regulation, predominantly ferritin.
Chelators bind and remove stored iron from ferritin/hemosiderin. Supplements increase available iron for storage and utilization. Hepcidin modulators regulate systemic iron release via ferroportin, indirectly affecting body iron stores.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin (primary iron storage protein), and Hemosiderin (secondary storage form in iron overload) (Ferritin (FT); Hemosiderin (no widely accepted abbreviation)).